In the last 90 days, RenovoRx, Inc. insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q3 2026, worth $19.1M in total; no superinvestor holds it.
SEC filings
10-K, 10-Q, 8-K, 20-F and 40-F reports RenovoRx, Inc. filed with the SEC, newest first.
Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.
2.02Item 2.02: Results of operations and financial condition (earnings release)8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
1.01Item 1.01: Entry into a material definitive agreement3.02Item 3.02: Unregistered sale of equity securities8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
5.02Item 5.02: Departure or appointment of directors or officers; executive pay arrangements8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
2.02Item 2.02: Results of operations and financial condition (earnings release)8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
2.02Item 2.02: Results of operations and financial condition (earnings release)8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
2.02Item 2.02: Results of operations and financial condition (earnings release)8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
2.02Item 2.02: Results of operations and financial condition (earnings release)8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
5.02Item 5.02: Departure or appointment of directors or officers; executive pay arrangements5.07Item 5.07: Results of a shareholder vote9.01Item 9.01: Financial statements and exhibits
4.01Item 4.01: Change in the company's certifying accountant (auditor)5.02Item 5.02: Departure or appointment of directors or officers; executive pay arrangements9.01Item 9.01: Financial statements and exhibits
3.02Item 3.02: Unregistered sale of equity securities7.01Item 7.01: Regulation FD disclosure8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
3.01Item 3.01: Notice of delisting or failure to meet a listing rule; transfer of listing5.02Item 5.02: Departure or appointment of directors or officers; executive pay arrangements
1.01Item 1.01: Entry into a material definitive agreement5.02Item 5.02: Departure or appointment of directors or officers; executive pay arrangements7.01Item 7.01: Regulation FD disclosure9.01Item 9.01: Financial statements and exhibits